Umikibart Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5956
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Umikibart Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
HGFï؟½
Concentration
5mg/ml
Isotype
IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P14210
Shipping Conditions
Blue ice
Background
Hepatocyte growth factor (HGF) signals through MET to control cell proliferation, motility, and survival, and its pathway is widely studied in cancer and tissue-repair research. This IgG4 recombinant human antibody is an unconjugated, non-therapeutic analog of umikibart that targets HGF, supplied for research use only (RUO). It is produced to in vivo-grade, low-endotoxin standards and offered in scalable milligram-to-gram quantities so that bulk and high-throughput laboratories can run extended studies. Investigators use it for ligand-neutralization assays, in vitro HGF/MET signaling screens, control applications, and preclinical tumor and regeneration models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Umikibart Biosimilar - Research Grade
Your Rating
Back to Top